These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 8042637)
21. [Somatostatin in the treatment of pancreatic diseases]. Németh AM Orv Hetil; 2002 May; 143(19 Suppl):1099-108. PubMed ID: 12063869 [TBL] [Abstract][Full Text] [Related]
22. [Management of digestive system carcinoid tumors and carcinoid syndrome]. Mondragón Sánchez RJ; Castillero Pinilla C; Saldívar Moreno C; Oñate Ocaña LF; Ruiz Molina JM; Aiello Crocifoglio V Rev Gastroenterol Mex; 1998; 63(4):204-10. PubMed ID: 10319670 [TBL] [Abstract][Full Text] [Related]
23. Efficacy of the somatostatin analog octreotide in the treatment of two patients with refractory diabetic diarrhea. Walker JJ; Kaplan DS Am J Gastroenterol; 1993 May; 88(5):765-7. PubMed ID: 8480746 [TBL] [Abstract][Full Text] [Related]
29. [Carcinoid tumor--diagnostic and therapeutic problems]. Batowski S; Bielewicz A Pol Tyg Lek; 1994 Jun 6-13; 49(23-24):536-7. PubMed ID: 7675710 [TBL] [Abstract][Full Text] [Related]
30. [Therapeutic applications of somatostatin and its analog, octreotide]. Harris AG; Kokoris SP Presse Med; 1993 Apr; 22(15):724-33. PubMed ID: 8099737 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of octreotide in the management of chronic diarrhoea in AIDS. Colebunders R; Sow S; Coulibaly M; Blot K AIDS; 1992 May; 6(5):512. PubMed ID: 1616659 [No Abstract] [Full Text] [Related]
32. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1. Lunsford LD; Flickinger JC; Larson D Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030 [TBL] [Abstract][Full Text] [Related]
33. Octreotide in the management of active acromegaly due to inoperable growth hormone-secreting adenoma. Candrina R Recenti Prog Med; 1994 Jan; 85(1):13-9. PubMed ID: 8184174 [TBL] [Abstract][Full Text] [Related]
34. Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects. Hofland LJ; van der Hoek J; Feelders R; van der Lely AJ; de Herder W; Lamberts SW J Endocrinol Invest; 2005; 28(11 Suppl International):36-42. PubMed ID: 16625843 [TBL] [Abstract][Full Text] [Related]
35. Clinical efficacy and safety of octreotide (SMS201-995) in terminally ill Japanese cancer patients with malignant bowel obstruction. Shima Y; Ohtsu A; Shirao K; Sasaki Y Jpn J Clin Oncol; 2008 May; 38(5):354-9. PubMed ID: 18490369 [TBL] [Abstract][Full Text] [Related]